Kincell Bio, LLC
The Associate III will operate automatic and manual cell therapy equipment for CAR‑T, CAR‑M, or CAR‑NK processes, perform quality control analyses, and handle hazardous materials. This role supports complex GMP manufacturing operations, leads high‑risk steps, and contributes to continuous improvement within the manufacturing team.
Headquarters
Durham, North Carolina, United States
Company Size
11-50 employees
Founded
2023
Kincell Bio is a contract development and manufacturing organization (CDMO) focused on development and manufacturing of cell therapies. They provide expert CMC and analytical development, clinical supply services, and support to create a clear path to commercialization. Kincell positions itself as a trusted partner for biotech and pharmaceutical teams seeking outsourced development, clinical‑stage manufacturing, and commercialization readiness for cell therapy programs.
Kincell Bio Announces New Board Chairman Mark R Bamforth To Accelerate Company's Growth And Expansion
May 21, 2024
Bruce Thompson, Ph.D.
Jul 13, 2023
Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership
Apr 16, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kincell Bio, LLC .
Kincell Bio, LLC didn’t post a salary, so this is our estimate from similar listings.
8% above the average for this role
Korea’s Ildong promotes Chae Joon Lee to co-CEO
Jan 16, 2026